UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000045816 |
|---|---|
| Receipt number | R000052307 |
| Scientific Title | Pharmacist education associate with pediatric coalition |
| Date of disclosure of the study information | 2021/10/21 |
| Last modified on | 2025/03/19 11:18:00 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Pharmacist education associate with pediatric coalition
Acronym
Pharmacist education associate with pediatric coalition
Scientific Title
Pharmacist education associate with pediatric coalition
Scientific Title:Acronym
Pharmacist education associate with pediatric coalition
Region
| Japan |
Condition
Condition
Pediatric care
Classification by specialty
| Pediatrics |
Classification by malignancy
Malignancy
Genomic information
NO
Objectives
Narrative objectives1
Perform and evaluation of pediatric coalition
Basic objectives2
Safety,Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Evaluation of adherence
Key secondary outcomes
1. Evaluation of curriculum for pediatric care
2. Case of pediatric coalition
Base
Study type
Interventional
Study design
Basic design
Single arm
Randomization
Non-randomized
Randomization unit
Blinding
Open -no one is blinded
Control
Self control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
1
Purpose of intervention
Treatment
Type of intervention
| Behavior,custom |
Interventions/Control_1
Pharmaceutical care
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| Not applicable |
Age-upper limit
| 15 | years-old | >= |
Gender
Male and Female
Key inclusion criteria
Home care patients with pediatric disease
Key exclusion criteria
withhold assent
Target sample size
10
Research contact person
Name of lead principal investigator
| 1st name | Yasumitsu |
| Middle name | |
| Last name | SHIMADA |
Organization
Chiba Pharmaceutical Association
Division name
Medical Cooperation Committee
Zip code
260-0025
Address
9-2 Tonyacho, Chuo-ku, Chiba-shi, Chiba, 260-0025 Japan
TEL
043-242-3801
springercustom2009@gmail.com
Public contact
Name of contact person
| 1st name | Kousuke |
| Middle name | |
| Last name | KOMAKI |
Organization
Chiba Pharmaceutical Association
Division name
Secretariat
Zip code
260-0025
Address
9-2 Tonyacho, Chuo-ku, Chiba-shi, Chiba, 260-0025 Japan
TEL
043-242-3801
Homepage URL
komaki@c-yaku.or.jp
Sponsor or person
Institute
Chiba Pharmaceutical Association
Institute
Department
Personal name
Funding Source
Organization
Ministry of Health, Labour and Welfare
Organization
Division
Category of Funding Organization
Japanese Governmental office
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Ethical Review Board, Chiba Pharmaceutical Association
Address
9-2 Tonyacho, Chuo-ku, Chiba-shi, Chiba, 260-0025 Japan
Tel
043-247-4401
drug-info@c-yaku.or.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2021 | Year | 10 | Month | 21 | Day |
Related information
URL releasing protocol
This study protocol is not available to the public.
Publication of results
Published
Result
URL related to results and publications
This study protocol is not available to the public.
Number of participants that the trial has enrolled
0
Results
0 patients included.
Results date posted
| 2025 | Year | 03 | Month | 19 | Day |
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
0 patients included.
Participant flow
0 patients included.
Adverse events
0 patients included.
Outcome measures
Adherence
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Completed
Date of protocol fixation
| 2021 | Year | 10 | Month | 19 | Day |
Date of IRB
| 2021 | Year | 10 | Month | 20 | Day |
Anticipated trial start date
| 2021 | Year | 10 | Month | 27 | Day |
Last follow-up date
| 2022 | Year | 02 | Month | 28 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Management information
Registered date
| 2021 | Year | 10 | Month | 21 | Day |
Last modified on
| 2025 | Year | 03 | Month | 19 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000052307
